{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_057173.3:c.6057G>A",
          "cDNA Change": {
            "transcript": "NM_057173.3",
            "ref": "G",
            "alt": "A",
            "position": "6057"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005231"
  },
  "Experiment Method": [
    {
      "Assay Method": "Genome-Wide Association Study (GWAS)",
      "Material used": {
        "Material Source": "Population cohorts",
        "Material Name": "Genome-wide data from Parkinson's patients and controls",
        "Description": "The study used genome-wide data from Parkinson's disease patients and control cohorts to identify genetic associations."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.3:c.6057G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The variant p.G2019S in LRRK2 was associated with increased risk of Parkinson's disease in GWAS analysis."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Logistic regression for case-control association analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "p-value ≥ 0.05 for association with disease.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "p-value < 5e-8 for genome-wide significance.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Functional Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells overexpressing LRRK2 p.G2019S",
        "Description": "Functional analysis was conducted using HEK293 cells overexpressing the LRRK2 p.G2019S variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057173.3:c.6057G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The p.G2019S variant in LRRK2 exhibited increased kinase activity in functional assays."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA for comparing kinase activity levels between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity ≥ 20% higher than wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}